PEDIATRICS Vol. 96 No. 1 July 1995, pp. 5-13
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandel, E. M.
Right arrow Articles by Kurs-Lasky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandel, E. M.
Right arrow Articles by Kurs-Lasky, M.

Efficacy of 20- Versus 10-Day Antimicrobial Treatment for Acute Otitis Media

Ellen M. Mandel MD1, Margaretha L. Casselbrant MD, PhD2, Howard E. Rockette PhD3, Charles D. Bluestone MD2, and Marcia Kurs-Lasky MS3

1 Otitis Media Research Center, the Departments of Pediatric Otolaryngology and Pediatrics, Children's Hospital of Pittsburgh, Departments of Otolaryngology and Pediatrics, University of Pittsburgh School of Medicine
2 Otitis Media Research Center, the Departments of Pediatric Otolaryngology and Pediatrics, Children's Hospital of Pittsburgh, Department of Otolaryngology, University of Pittsburgh School of Medicine
3 Otitis Media Research Center, the Departments of Pediatric Otolaryngology and Pediatrics, Children's Hospital of Pittsburgh, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health

Objective. The purpose of this trial was to determine whether 20 days of antimicrobial treatment is more efficacious than 10 days of treatment for acute otitis media (AOM) in clearing middle ear effusion and preventing recurrences of AOM, and whether changing to a beta-lactamase-stable antimicrobial agent after the initial 10-day treatment with amoxicillin for AOM is advantageous.

Methods. Children between 7 months and 12 years of age with AOM were randomly assigned to three treatment groups: (1) amoxicillin for days 1 through 10, then amoxicillin for days 11 through 20; (2) amoxicillin for days 1 through 10, then amoxicillin-clavulanate for days 11 through 20; and (3) amoxicillin for days 1 through 10, then a placebo for either amoxicillin or amoxicillin-clavulanate for days 11 through 20. Medication was dispensed in a double-blind manner. Children underwent tympanocentesis at entry and were re-examined on days 10, 20, 30, 60, and 90 after entry.

Results. Two hundred sixty-seven children entered the trial. At the 20-day visit, the percentages of children who were effusion free in the amoxicillin, amoxicillin-clavulanate, and placebo groups were 72.4%, 80.8%, and 52.5%, respectively. There was no statistically significant difference in the percentage of children who were effusion free between the amoxicillin and amoxicillin-clavulanate groups (95% confidence interval, -21.7, 4.9). Subsequent to the day 10 visit, the average proportions of time with middle ear effusion were not significantly different in the amoxicillin, amoxicillin-clavulanate, and placebo groups (0.29, 0.27, and 0.34, respectively), nor were there significant differences in the rates of recurrent episodes of AOM (0.56, 0.59, and 0.68, respectively). Regardless of treatment group, approximately 75% of children were effusion free at the time of their last visit.

Conclusions. More children were effusion free by the day 20 visit if given antimicrobial treatment for 20 days rather than for 10 days, but this advantage was present for only a short time; by the end of the 90-day study period, the treatment groups were comparable with regard to effusion status. Recurrence of AOM during the study period was not prevented by the additional 10 days of treatment. Routine use of an additional 10-day course of antimicrobial treatment is therefore not recommended if a child is symptom free after the initial 10 days of treatment for AOM.

Submitted on August 9, 1994
Accepted on October 27, 1994




This article has been cited by other articles:


Home page
 BMJHome page
R. A M J Damoiseaux, F. A M van Balen, A. W Hoes, T. J M Verheij, and R. A de Melker
Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years
BMJ, February 5, 2000; 320(7231): 350 - 354.
[Abstract] [Full Text]

Home page
 JAMAHome page
A. L. Kozyrskyj, G. E. Hildes-Ripstein, S. E. A. Longstaffe, J. L. Wincott, D. S. Sitar, T. P. Klassen, and M. E. K. Moffatt
Treatment of Acute Otitis Media With a Shortened Course of Antibiotics: A Meta-analysis
JAMA, June 3, 1998; 279(21): 1736 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. D. Barnett, D. W. Teele, J. O. Klein, H. J. Cabral, S. J. Kharasch, and the Greater Boston Otitis Media Study Group
Comparison of Ceftriaxone and Trimethoprim-Sulfamethoxazole for Acute Otitis Media
Pediatrics, January 1, 1997; 99(1): 23 - 28.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
20-DAY VS. 10-DAY TREATMENT OF ACUTE OTITIS MEDIA
Journal Watch (General), July 28, 1995; 1995(728): 4 - 4.
[Full Text]